“ Screening for hotspot mutations in PI3K, JAK2, FLT3 and NPM1 in patients with myelodysplastic syndromes ”, Clinics, vol. 66, no. 5, pp. 793–799, Jan. 2011, doi: 10.1590/S1807-59322011000500014.